Electromedical Technologies EMED Growth Metrics (2019-2024)

OTC EMED
$0.00 +0.00 (+0.00%)
At close: Oct 19, 2026 · 4:00 PM EDT
Reported Financials

Electromedical Technologies Quarterly Growth Metrics

Periods 21 quarters
Latest Sep 2024

Electromedical Technologies reported revenue growth of -86.86% and asset growth of -33.35% for the quarter ended Sep 2024. These growth metrics cover 21 quarters of results from Sep 2019 through Sep 2024, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024
Growth Ratios
Assets Growth (1y)
56.94%33.64%-1.56%-1.05%-30.84%17.50%-3.48%3.32%-39.27%-44.70%-54.99%-35.55%-33.35%
Assets Growth (3y)
14.44%-1.52%-11.11%-19.17%-25.24%-22.77%-21.94%
Assets (QoQ)
12.45%16.64%19.43%-14.69%-17.17%17.23%40.73%-3.70%16.07%-34.32%-17.28%-12.31%-5.53%-5.95%-14.46%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
199.38%92.81%44.64%-82.85%178.45%-3.85%538.15%-69.83%-76.19%-93.62%-71.91%-74.86%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
48.51%17.45%-30.82%-48.61%-32.51%-40.45%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
-32.74%209.92%119.23%-34.49%-56.68%132.49%603.54%-19.72%235.22%-66.30%-66.73%-36.67%-10.10%48.31%-70.23%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ)
-107.90%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
-221.87%-15.52%-46,915.02%-62.71%67.70%46.84%2.87%75.60%-82.73%88.49%-42.44%-549.44%14.39%-53.93%65.02%117.13%88.90%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
-39.58%58.65%-766.10%-37.13%20.35%54.50%21.49%31.45%44.21%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y)
-15.64%
Cash from Operations (QoQ)Cash from Ops. (QoQ)
-203.83%100.15%-35,382.12%-122.90%1.58%39.51%-22.62%55.75%-61.98%-10.51%69.19%-231.37%89.80%-1,267.82%-40.46%56.32%81.66%-210.83%168.78%-128.30%
EBITDA Margin Growth (1y)
-0.05M-0.10M0.07M-0.01M0.07M0.13M-0.10M0.01M-0.02M-0.04M0.05M289.000.00M0.00M-0.01M0.02M-0.01M-0.09M
EBITDA Margin Growth (3y)
0.00M0.00M0.02M0.00M0.06M0.10M-0.05M0.03M-0.02M-0.12M
EBITDA Margin Growth (5y)
496.00-0.09M
EBITDA Margin (QoQ)
-0.02M0.00M-0.04M-0.04M0.15M-0.08M0.04M0.02M-0.08M0.03M0.02M500.000.01M-0.02M0.02M77.000.00M0.00M-0.01M-0.08M
EBIT Growth (1y)
-317.27%-1,073.78%135.77%-257.37%35.85%89.47%-910.39%53.62%46.01%-52.95%82.74%-73.87%-20.53%29.15%13.35%87.72%26.23%-59.41%
EBIT Growth (3y)
-13.06%-23.65%20.61%-42.30%25.27%51.50%-47.55%53.74%21.70%-19.99%
EBIT Growth (5y)
-5.14%-16.38%
EBIT Margin Growth (1y)
-0.05M-0.10M0.04M-0.07M0.03M0.09M-0.07M0.06M0.01M0.00M0.06M-619.000.00M0.00M-260.000.03M977.00-0.08M
EBIT Margin Growth (3y)
0.00M-0.01M0.02M-0.01M0.05M0.09M-0.02M0.09M0.02M-0.08M
EBIT Margin Growth (5y)
299.00-0.08M
EBIT Margin (QoQ)
-0.02M0.00M-0.04M-0.04M0.11M-0.10M0.07M0.02M-0.06M0.03M0.02M507.000.01M-0.03M0.02M0.00M0.00M0.00M-0.01M-0.08M
EBIT (QoQ)
-188.11%14.86%-86.83%-156.13%108.78%-950.64%66.47%57.96%-575.74%51.32%60.96%-19.10%23.73%-390.24%72.94%29.99%6.72%30.54%-62.61%-51.30%
EBT Growth (1y)
-301.01%-1,035.82%5.66%-479.77%-55.82%38.27%-270.71%64.23%67.64%62.44%71.18%-75.70%-49.12%19.44%47.71%87.02%50.45%-8.68%
EBT Growth (3y)
-26.45%-38.10%-0.27%-53.88%9.07%42.84%17.64%56.63%37.93%30.98%
EBT Growth (5y)
-8.36%-18.18%
EBT Margin Growth (1y)
-0.05M-0.10M0.00M-0.14M0.00M0.06M-0.05M0.12M0.05M0.03M0.07M0.00M0.00M0.01M0.00M0.04M0.01M-0.09M
EBT Margin Growth (3y)
-0.01M-0.01M0.01M-0.02M0.04M0.09M0.02M0.15M0.05M-0.06M
EBT Margin Growth (5y)
0.00M-0.10M
EBT Margin (QoQ)
-0.02M0.00M-0.04M-0.04M0.08M-0.13M0.09M0.02M-0.03M0.04M0.02M822.000.01M-0.03M0.02M0.01M0.00M621.00-0.01M-0.09M
EBT (QoQ)
-182.26%15.17%-83.87%-157.98%76.55%-421.32%50.58%-2.20%-40.80%49.70%55.30%-18.63%-8.04%-206.65%62.06%35.91%29.87%23.86%-44.80%-40.56%
EPS (Basic) Growth (1y)
-206.21%-768.04%39.76%-332.76%-173.38%38.65%-99.09%88.45%95.82%89.07%82.53%84.74%6.60%87.85%85.41%5.10%110.26%-31.69%
EPS (Basic) Growth (3y)
29.52%16.51%40.60%57.59%52.56%79.88%62.98%74.42%26.08%74.05%
EPS (Basic) Growth (5y)
15.25%37.80%
EPS (Basic) (QoQ)
-167.21%18.63%-64.61%-142.54%81.46%-484.50%-3.99%45.57%39.82%66.09%62.34%-42.23%3.80%70.37%-130.40%81.50%-15.52%-92.74%124.92%-337.33%
EPS (Diluted) Growth (1y)
-99.09%88.45%95.82%89.07%82.53%84.74%6.60%87.85%85.41%5.10%110.26%-73.89%
EPS (Diluted) Growth (3y)
62.98%74.42%26.08%71.53%
EPS (Diluted) (QoQ)
-484.48%-3.99%45.57%39.82%66.09%62.34%-42.23%3.80%70.37%-130.40%81.50%-15.52%-92.74%124.92%-413.38%
FCF Margin Growth (1y)
-0.04M-0.01M-0.02M0.00M0.02M0.02M0.01M0.02M-0.01M0.01M0.00M-0.02M0.00M-667.000.01M0.03M0.00M
FCF Margin Growth (3y)
-0.03M0.02M-0.01M0.00M0.02M0.03M0.01M0.02M0.00M
FCF Margin Growth (5y)
-0.02M
FCF Margin (QoQ)
-0.04M0.02M-0.02M-0.01M0.00M0.01M-111.000.01M-0.01M0.00M0.01M-0.01M0.01M-0.01M-0.01M0.01M0.01M0.00M0.01M-0.01M
Free Cash Flow Growth (1y)FCF Growth (1y)
-221.87%-15.52%-46,915.02%-62.71%67.70%46.84%2.87%75.60%-82.73%88.49%-42.44%-549.44%14.39%-53.93%65.02%117.13%88.90%
Free Cash Flow Growth (3y)FCF Growth (3y)
-39.58%58.65%-766.10%-37.13%20.35%54.50%21.49%31.45%44.21%
Free Cash Flow Growth (5y)FCF Growth (5y)
-15.64%
Free Cash Flow (QoQ)FCF (QoQ)
-203.83%100.15%-35,382.12%-122.90%1.58%39.51%-22.62%55.75%-61.98%-10.51%69.19%-231.37%89.80%-1,267.82%-40.46%56.32%81.66%-210.83%168.78%-128.30%
Gross Margin Growth (1y)
0.00M-4.00-230.00504.000.00M572.000.00M-549.00438.00141.00-394.00732.00-107.00-163.00-162.00-194.00-590.00-555.00
Gross Margin Growth (3y)
552.00709.00657.00686.00-804.00549.00725.00-11.00-259.00-578.00
Gross Margin Growth (5y)
-145.00-10.00
Gross Margin (QoQ)
-6.00-213.000.00M0.00M-232.00520.0048.00235.00477.000.00M0.00M-62.00-57.00-184.00196.00-119.00-55.00-216.00-199.00-84.00
Gross Profit Growth (1y)
-11.22%-23.83%-14.65%-16.96%29.01%57.90%55.28%23.55%17.43%-5.49%70.17%88.62%29.19%13.38%-18.62%-25.28%-25.46%-87.80%
Gross Profit Growth (3y)
10.39%4.36%31.14%24.61%25.09%19.16%29.08%20.30%4.18%-49.25%
Gross Profit Growth (5y)
5.31%-30.93%
Gross Profit (QoQ)
-24.27%1.86%-21.01%25.01%-15.14%-0.91%22.72%53.01%-16.54%-21.16%16.64%23.14%50.28%-12.61%-20.11%8.06%7.87%-19.77%-20.30%-82.31%
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y)
-231.83%-136.30%101.01%94.96%98.79%99.50%-1,581.59%-130.44%-205.61%-952.66%76.87%4.43%42.18%29.83%-316.79%19.66%-259.96%-370.62%
Interest Coverage Ratio Growth (3y)Interest Cover Growth (3y)
50.32%50.03%67.38%51.95%72.25%66.66%-153.46%-20.95%-85.28%-226.37%
Interest Coverage Ratio Growth (5y)Interest Cover Growth (5y)
23.90%16.25%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
-56.85%-10.91%-91.78%29.17%100.67%-651.49%53.97%70.61%-1,886.00%14.22%38.96%-1.23%56.36%-254.42%63.07%-22.86%-159.19%31.68%-65.45%-60.63%
Net Cash Flow Growth (1y)NCF Growth (1y)
-111.09%147.84%712.38%-327.15%-418.36%21.69%-167.47%47.68%282.57%-141.44%506.62%-681.13%-170.56%43.89%-101.02%104.65%70.44%
Net Cash Flow Growth (3y)NCF Growth (3y)
1.63%37.75%181.42%-124.29%-88.31%-31.67%-26.58%29.86%27.52%
Net Cash Flow Growth (5y)NCF Growth (5y)
-17.28%
Net Cash Flow (QoQ)NCF (QoQ)
-200.00%110.37%126.83%-147.17%531.35%76.03%-163.42%-7.64%201.26%-197.60%50.82%475.59%-122.99%1,057.68%-194.48%66.07%81.72%82.55%529.84%-315.61%
Net Income Growth (1y)
-279.49%-1,038.32%20.08%-467.41%7.82%-52.07%-349.84%55.30%30.81%70.97%55.02%60.15%-172.39%60.67%58.00%-83.37%115.84%-92.36%
Net Income Growth (3y)
-34.27%-71.28%-17.38%-0.35%-20.22%44.21%5.28%31.13%31.97%39.67%
Net Income Growth (5y)
24.94%-30.61%
Net Income (QoQ)
-169.28%12.09%-86.21%-158.25%81.09%-524.11%69.75%-326.04%44.07%37.98%53.17%-78.74%13.35%45.06%-220.09%74.19%7.45%-139.86%127.65%-413.38%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
-279.49%-1,038.32%20.08%-580.48%-376.59%-52.45%-355.23%60.66%86.62%70.45%54.23%62.24%-173.03%61.47%58.81%-83.37%115.80%-92.36%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
-34.27%-72.45%-18.53%-0.35%-20.31%44.21%4.97%35.18%27.19%39.72%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
24.94%-30.61%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
-169.28%12.09%-86.21%-158.25%81.09%-648.48%-30.42%17.39%43.55%35.32%55.63%-82.44%12.57%46.65%-220.85%74.25%6.53%-137.50%127.65%-413.38%
Net Margin Growth (1y)
-0.05M-0.10M0.00M-0.16M-0.14M0.00M-0.06M0.13M0.17M0.07M0.06M0.04M-0.03M0.02M0.01M-0.02M0.06M-0.16M
Net Margin Growth (3y)
-0.01M-0.03M0.00M0.01M0.01M0.09M0.01M0.16M0.21M-0.06M
Net Margin Growth (5y)
0.02M-0.16M
Net Margin (QoQ)
-0.02M0.00M-0.04M-0.04M0.08M-0.16M-0.01M0.09M0.03M0.02M0.03M-0.01M0.01M0.01M-0.04M0.04M0.00M-0.02M0.04M-0.18M
Operating Income Growth (1y)Op. Inc Growth (1y)
-317.27%-1,073.78%135.77%-257.37%35.85%89.47%-910.39%53.62%46.01%-52.95%82.74%-73.87%-20.53%29.15%13.35%87.72%26.23%-59.41%
Operating Income Growth (3y)Op. Inc Growth (3y)
-13.06%-23.65%20.61%-42.30%25.27%51.50%-47.55%53.74%21.70%-19.99%
Operating Income Growth (5y)Op. Inc Growth (5y)
-5.14%-16.38%
Operating Income (QoQ)Op. Inc (QoQ)
-188.11%14.86%-86.83%-156.13%108.78%-950.64%66.47%57.96%-575.74%51.32%60.96%-19.10%23.73%-390.24%72.94%29.99%6.72%30.54%-62.61%-51.30%
Operating Margin Growth (1y)
-0.05M-0.10M0.04M-0.07M0.03M0.09M-0.07M0.06M0.01M0.00M0.06M-619.000.00M0.00M-260.000.03M977.00-0.08M
Operating Margin Growth (3y)
0.00M-0.01M0.02M-0.01M0.05M0.09M-0.02M0.09M0.02M-0.08M
Operating Margin Growth (5y)
299.00-0.08M
Operating Margin (QoQ)
-0.02M0.00M-0.04M-0.04M0.11M-0.10M0.07M0.02M-0.06M0.03M0.02M507.000.01M-0.03M0.02M0.00M0.00M0.00M-0.01M-0.08M
Profit After Tax Growth (1y)PAT Growth (1y)
-301.01%-1,035.82%5.66%-479.77%-55.82%38.27%-270.71%64.23%67.64%62.44%71.18%-75.70%-49.12%19.44%47.71%87.02%50.45%-8.68%
Profit After Tax Growth (3y)PAT Growth (3y)
-26.45%-38.10%-0.27%-53.88%9.07%42.84%17.64%56.63%37.93%30.98%
Profit After Tax Growth (5y)PAT Growth (5y)
-8.36%-18.18%
Profit After Tax (QoQ)PAT (QoQ)
-182.26%15.17%-83.87%-157.98%76.55%-421.32%50.58%-2.20%-40.80%49.70%55.30%-18.63%-8.04%-206.65%62.06%35.91%29.87%23.86%-44.80%-40.56%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)
-2.84%-2.88%-2.90%-2.92%-2.94%-2.96%-2.99%-3.01%-79.10%-78.94%-78.78%0.00%0.00%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y)
-2.92%-41.82%-41.68%-41.54%-41.39%-41.25%-41.10%
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ)
-0.72%-0.72%-0.73%-0.74%-0.74%-0.75%-0.75%-0.76%-0.76%-0.77%0.00%0.00%0.00%0.00%0.00%
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
-0.01M-0.02M0.01M0.04M0.00M-0.02M318.000.01M0.01M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
455.00-0.01M0.02M0.02M0.02M
Return on Assets [ROA] (QoQ)ROA (QoQ)
0.00M-0.01M0.00M0.00M-0.01M0.01M0.00M0.00M-0.01M0.00M0.02M0.00M0.00M
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
-0.05M-0.10M0.04M-0.07M0.03M0.09M-0.07M0.06M0.01M0.00M0.06M-619.000.00M0.00M-260.000.03M977.00-0.08M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
0.00M-0.01M0.02M-0.01M0.05M0.09M-0.02M0.09M0.02M-0.08M
Return on Sales [ROS] Growth (5y)ROS Growth (5y)
299.00-0.08M
Return on Sales [ROS] (QoQ)ROS (QoQ)
-0.02M0.00M-0.04M-0.04M0.11M-0.10M0.07M0.02M-0.06M0.03M0.02M507.000.01M-0.03M0.02M0.00M0.00M0.00M-0.01M-0.08M
Revenue Growth (1y)
-23.98%-23.80%-11.84%-22.54%48.41%46.30%31.21%33.32%10.99%-7.17%78.69%70.64%30.94%15.76%-16.91%-23.35%-19.43%-86.86%
Revenue Growth (3y)
7.78%1.15%27.38%20.79%29.20%16.28%24.89%20.37%5.40%-47.93%
Revenue Growth (5y)
5.73%-30.91%
Revenue (QoQ)
-24.21%4.96%-36.35%50.52%-12.32%-7.78%21.94%48.39%-21.37%-6.30%1.51%24.11%51.37%-10.52%-22.10%9.72%8.65%-17.45%-18.12%-82.11%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)
-86.53%-88.68%-1,247.52%339.85%-14.19%326.54%-72.16%-97.95%97.73%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y)
-51.29%-18.96%34.29%
Share-based Compensation (QoQ)Stock Comp. (QoQ)
-3.01%528.62%-98.14%0.00%-9,933.83%340.95%25,862.51%-70.39%-98.70%2,760.00%
Total Debt Growth (1y)
-9.75%-8.07%-7.34%-6.69%-4.57%-4.72%-4.89%-71.94%-71.60%195.98%0.00%0.00%927.37%
Total Debt Growth (3y)
-7.13%-37.32%-36.94%37.98%-35.79%-35.54%40.61%
Total Debt (QoQ)
-1.80%-1.78%-3.57%-1.16%-1.02%-1.09%-1.18%-1.26%-71.24%0.00%0.00%929.07%-90.28%0.00%927.37%

Electromedical Technologies Growth Metrics API

Pull Electromedical Technologies's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=EMED&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY